Intrinsic Value of S&P & Nasdaq Contact Us

XOMA Royalty Corp. XOMA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
69/100
4/7 Pass
SharesGrow Intrinsic Value
$14.46
-64%
Analyst Price Target
$68.25
+70.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

XOMA Royalty Corp. (XOMA) trades at a trailing P/E of 22.0, forward P/E of 36.4. Trailing earnings yield is 4.55%, forward earnings yield 2.75%. PEG 1.25. Graham Number is $14.50.

Criteria proven by this page:

  • VALUE (92/100, Pass) — P/E is below market average (22.0); analyst target implies upside (+70.1%); earnings yield beats bond yields (4.55%).
  • PEG Ratio 1.25 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield 4.55% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
  • Analyst consensus target $68.25 (+70.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 69/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
69/100
SG Score
View full scorecard →
VALUE
92/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
41/100
→ Income
GROWTH
100/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — XOMA

Valuation Multiples
P/E (TTM)22.0
Forward P/E36.4
PEG Ratio1.25
Forward PEG1.25
P/B Ratio6.21
P/S Ratio8.15
EV/EBITDA33.0
Per Share Data
EPS (TTM)$1.63
Forward EPS (Est.)$1.10
Book Value / Share$5.75
Revenue / Share$2.88
FCF / Share$0.15
Yields & Fair Value
Earnings Yield4.55%
Forward Earnings Yield2.75%
Dividend Yield0.00%
Graham Number$14.50
SharesGrow IV$14.46 (-64%)
Analyst Target$68.25 (+70.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -0.5 0.00 -0.54 4.57 -
2017 18.6 -0.17 46.88 5.15 -
2018 -7.9 0.03 5.64 19.99 -
2019 -120.7 2.70 5.44 13.02 -
2020 35.4 -0.18 5.45 16.03 -
2021 14.9 -0.94 1.66 6.17 1.49%
2022 -12.3 0.03 1.69 34.84 2.61%
2023 -5.2 -0.05 2.39 44.60 2.58%
2024 -22.2 0.38 3.75 10.79 1.78%
2025 15.1 -0.08 4.60 9.17 1.14%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-8.89 $5.56M $-53.53M -962.1%
2017 $0.73 $52.69M $14.6M 27.7%
2018 $-1.59 $5.3M $-13.34M -251.8%
2019 $-0.88 $18.37M $-7.7M -41.9%
2020 $1.16 $29.39M $13.3M 45.3%
2021 $1.30 $38.16M $15.8M 41.4%
2022 $-1.50 $6.03M $-17.1M -283.8%
2023 $-4.04 $4.76M $-40.83M -858.2%
2024 $-0.71 $28.49M $-13.82M -48.5%
2025 $1.46 $52.15M $31.71M 60.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.10 $-0.29 – $2.42 $66.23M $61.57M – $70.88M 4
2027 $0.69 $-0.05 – $1.41 $60.95M $49.08M – $79.49M 2
2028 $1.80 $0.45 – $3.15 $81.45M $65.59M – $106.22M 2
2029 $2.55 $1.90 – $3.55 $97.45M $78.47M – $127.09M 1
2030 $3.07 $2.29 – $4.28 $120.65M $97.15M – $157.34M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message